In contrast, a DL model can offer precise, AI-generated coding suggestions for adverse events and concomitant medications at up to 99% accuracy. The model can adapt to different scenarios, removing ...
Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...
Discover the top 7 Enterprise Risk Management (ERM) tools for CIOs in 2025. Explore detailed reviews, features, pricing, and ...
Motive’s AI coach provides the feedback while its tech cuts time spent on manual processes by up to 35%, says VP Nyanya Joof ...
Researchers led by Wake Forest University School of Medicine and Atrium Health have judged the certainty of evidence on ...
A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is investigating how advanced brain ...
T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...
Preserving trial integrity. Clinical trials are susceptible to timing. Delays in investigational product delivery can stall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback